0 216

Cited 1 times in

Preclinical activity of NVL-655 in patient-derived models of ALK cancers, including those with lorlatinib-resistant G1202R/L1196M compound mutation

Authors
 T. Fujino  ;  L. Nguyen  ;  S. Yoda  ;  M. Yu  ;  H. Mizuta  ;  L. Bigot  ;  C. Nobre  ;  A. Tangpeerachaikul  ;  H.E. Pelish  ;  L. Friboulet  ;  J. Lee  ;  B. Cho  ;  A.N. Hata 
Citation
 EUROPEAN JOURNAL OF CANCER, Vol.174 : S78-S79, 2022-10 
Journal Title
EUROPEAN JOURNAL OF CANCER
ISSN
 0959-8049 
Issue Date
2022-10
Full Text
https://www.sciencedirect.com/science/article/pii/S0959804922010085
DOI
10.1016/S0959-8049(22)01008-5
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Cho, Byoung Chul(조병철) ORCID logo https://orcid.org/0000-0002-5562-270X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/193291
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links